Lindesnes, Norway

Arne Askildsen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Arne Askildsen: Innovator in X-ray Contrast Agents

Introduction

Arne Askildsen is a notable inventor based in Lindesnes, Norway. He has made significant contributions to the field of medical imaging, particularly in the development of non-ionic X-ray contrast agents. With a total of 3 patents to his name, Askildsen's work has had a substantial impact on the healthcare industry.

Latest Patents

Among his latest patents, Askildsen has developed an alternative process for the purification of an intermediate in the synthesis of non-ionic X-ray contrast agents. This includes alternative continuous downstream processes for the production of 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide, commonly referred to as 'Compound A'. Compound A is a key intermediate in the production of iodixanol and iohexol, which are two of the most commercially available non-ionic X-ray contrast media agents.

Career Highlights

Arne Askildsen is currently employed at GE Healthcare AS, where he continues to innovate and contribute to advancements in medical imaging technology. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Throughout his career, Askildsen has collaborated with talented professionals, including Torfinn Haaland and Rita Heskestad Kalleberg. These collaborations have further enhanced his research and development efforts in the field of X-ray contrast agents.

Conclusion

Arne Askildsen's contributions to the field of medical imaging through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of non-ionic X-ray contrast agents, benefiting the healthcare industry and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…